NCT03608072View on ClinicalTrials.gov

A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Healthy
Interventions
DRUG

BI 690517

3 sequential dose groups

DRUG

Placebo

3 sequential dose groups

Trial Locations (1)

130-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03608072 - A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated | Biotech Hunter | Biotech Hunter